Marijuana Stocks Newsletter – Monday August 13, 2018

0
906

What’s Next For GT Biopharma (GTBP)?
During the period January 2018 – the present we have been watching the price, news and corporate developments at (GTBP).The company has added an ALL-STAR management roster, increased the strength of its board and received positive results on clinical trials. GT Biopharma (GTBP) has also begun to align itself with a “Major Pharma” company & that could present even more potential ahead.
Click Here For More


Beleave, Inc. (BLEVF) Readying For Canada’s Next Move
A financial boom not seen since the dot-com mania of the late 1990s has taken over Canada. The legalization of recreational marijuana, scheduled for this fall, is not only a momentous social event, but also a rare opportunity for to be in on the birth of what they hope will become a multibillion-dollar industry. One Company Has Put Its Wheels In Motion & That Could Mean Big Potential Ahead
Click Here For More Information


Aspects of the Cannabis Market That Some Investors Miss
The cannabis industry has been around for several years now, but it still remains an industry that is very much in its infant stages. As we move across the course of the next few years, it seems as though there are more principles to investing in this industry than ever before.
More Details Here


Disclaimer: Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and GT Biopharma, Midam has been paid $200,000 from the company and ZERO shares of GT Biopharma Inc. for a duration beginning July 16, 2018 and ending August 16, 2018. Midam Ventures has been paid an additional $200k by GT Biopharma and has extended its marketing period through Sept 16, 2018. We may buy or sell additional shares of (GTBP) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and Beleave Inc., Midam has been paid $200,000 from the company and ZERO shares of Beleave Inc. for a duration of 6 weeks beginning June 18, 2018 and ending July 31, 2018 NOW EXTENDED TO 8/31/2018. We may buy or sell additional shares of (BLEVF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

LEAVE A REPLY

Please enter your comment!
Please enter your name here